市場調查報告書
商品編碼
1549984
小動物成像的全球市場:產品 (光學成像·核成像·試劑)·用途·不同地區的預測 (~2032年)Global Small Animal Imaging Market Research Report Information by Product Optical Imaging, Nuclear Imaging, Reagent, by Application, by Region - Forecast to 2032 |
小動物影像市場規模預計將從 2022 年的 11.2 億美元成長到 2023 年的 11.9 億美元,預測期內複合年增長率為 6.87%,到 2032 年將成長到 23.2 億美元。
製藥業研發費用的增加和小動物研究意識的增強是市場擴張的驅動力。
各方面對小動物研究的日益認可正在對小動物影像產業的成長產生重大影響。隨著越來越多的利害關係人認識到小動物模型在臨床前研究中發揮的重要作用,對先進成像技術的需求不斷增長,以實現對小動物模型進行更精確和更廣泛的研究。
此外,研究人員正在認識到小動物影像在闡明疾病原因、評估治療介入和預測臨床結果方面的效用,這正在推動新影像技術的採用。隨著資助機構、政府和監管機構越來越意識到支持小動物研究的必要性,該產業也得到了增加投資和更好監管環境的支持。
區域展望
2022年北美市場佔比最高。這是由於北美寵物慢性病盛行率不斷上升,以及藥品和生技研發活動的增加。
由於製藥和生物技術行業對臨床前成像的需求不斷增加、政府對分子成像研發的補貼增加以及主要成像設備製造商在該地區的強勢存在,歐洲市場的佔有率位居第二。因素。
亞太地區預計從 2023 年到 2032 年將大幅成長。這是由於該地區醫療保健支出的增加、藥物發現和開發的臨床前研究需求的增加以及 MRI、CT、PET 和 SPECT 等成像模式的技術進步。
本報告提供全球小動物成像的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的轉變·預測,各種區分·各地區的明細,競爭環境,主要企業簡介等資訊。
Global Small Animal Imaging Market Research Report Information by Product Optical Imaging (Photoacoustic Tomography and Optical Coherence Tomography), Nuclear Imaging (Micro PET System, Micro SPECT System, Micro MRI System, Micro CT System, and Others), Reagent (Optical Image Reagent, Contrast Agent, Pet Tracers, and SPECT Probe), by Application (Monitoring Drug Treatment Programme, Bio Distribution Studies, Cancer Cell Detection, Biomarkers, and Longitudinal Studies), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast to 2032
In 2022, the Small Animal Imaging Market is expected to be worth USD 1.12 billion. During the projected period (2023-2032), the small animal imaging market is predicted to increase at a compound annual growth rate (CAGR) of 6.87%, from USD 1.19 billion in 2023 to USD 2.32 billion in 2032. The pharmaceutical industry's increased expenditure in R&D, as well as expanding awareness of small animal research, are driving market expansion.
The increasing awareness of small animal research on a variety of fronts has a substantial impact on the growth of the small animal imaging industry. Initially, demand for sophisticated imaging technologies capable of enabling more precise and extensive studies in small animal models is increasing as more stakeholders recognize the critical role that these models play in preclinical research.
Furthermore, researchers recognize the usefulness of small animal imaging in explaining disease causes, evaluating therapeutic interventions, and predicting clinical outcomes, which is driving the adoption of novel imaging modalities. Furthermore, the industry is being boosted by growing investment and favorable regulatory settings as funding agencies, governments, and regulatory authorities become more conscious of the need of supporting small animal research.
Market segmentation insights
The Small Animal Imaging Market is segmented by product into imaging modality and reagent. Imaging modality is further subdivided into optical imaging and nuclear imaging. Imaging studies are organized into three basic categories: computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography. Additionally, optical imaging is classified into two types: photoacoustic tomography and optical coherence tomography. Nuclear imaging is further classified into five categories: micro-PET systems, micro SPECT systems, micro MRI systems, micro CT systems, and others.
The Small Animal Imaging Market is segmented by application, which includes medication treatment program surveillance, bio distribution studies, cancer cell detection, biomarkers, and long-term research.
Regional Perspectives
In 2022, the North American small animal imaging market had the highest market share. The cause for this is the rising prevalence of chronic diseases in pets in North America, as well as increased research and development activities in medicines and biotechnology.
The second-largest market share in the European small animal imaging market is due to rising demand for preclinical imaging in the pharmaceutical and biotechnology industries, increased government funding for molecular imaging research and development, and the region's strong presence of leading imaging equipment manufacturers.
The Asia-Pacific small animal imaging market is expected to increase significantly between 2023 and 2032. This is due to the region's rising healthcare spending, increased demand for preclinical research in drug discovery and development, and technological advances in imaging modalities such as MRI, CT, PET, and SPECT.
The key companies in the Small Animal Imaging Market include Bruker (US), Analytik Jena GmbH+Co. KG (Germany), Aspect Imaging Ltd (US), MR Solutions (UK), FUJIFILM Holdings Corporation (Japan), MILabs B.V. (Netherlands), Trifoil Imaging (US), Mediso Ltd (Hungary), LI-COR, Inc (US), and Heska Corporation (US).